Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival
oleh: Sophie Robin, Sylvie Chabaud, Anne-Agathe Serre, Béatrice Bringeon, Sébastien Clippe, François Rocher, Olivier Desmettre, Gabriel Bringeon, Frédéric Gassa, Pascal Pommier
| Format: | Article |
|---|---|
| Diterbitkan: | Termedia Publishing House 2021-08-01 |
Deskripsi
Subjek
prostate; brachytherapy; intermediate-risk; guidelines; prognostic criteria.